Product
AK111
4 clinical trials
3 indications
Indication
Ankylosing spondylitisIndication
PsoriasisIndication
Skin DiseasesClinical trial
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing SpondylitisStatus: Completed, Estimated PCD: 2022-04-25
Clinical trial
A Randomized, Double-blind, Phase II Clinical Study to Evaluate the Efficacy and Safety of AK111 in the Treatment of Subjects With Moderate to Severe Plaque PsoriasisStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Clinical Study to Evaluate the Efficacy and Safety of AK111 in the Treatment of Subjects With Active Ankylosing SpondylitisStatus: Recruiting, Estimated PCD: 2025-02-28
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Clinical Study to Evaluate the Efficacy and Safety of AK111 in the Treatment of Subjects With Moderate to Severe Plaque PsoriasisStatus: Active (not recruiting), Estimated PCD: 2023-12-01